-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2017 to 2021.
- LogicBio Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$9.9M, a 22.6% decline year-over-year.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$19M, a 34.3% increase from 2020.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$28.9M, a 25.4% increase from 2019.
- LogicBio Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2019 was -$38.8M, a 154% decline from 2018.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)